MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 6, 2004; DOI: 10.1124/mol.104.001370


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.001370v1
67/1/250    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Val J. Watts
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beazely, M. A.
Right arrow Articles by Watts, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beazely, M. A.
Right arrow Articles by Watts, V. J.


Received for publication April 16, 2004.
Revised October 5, 2004.
Accepted for publication October 5, 2004.

PKC and EGF stimulation of Raf1 potentiates AC6 activation in intact cells

Michael A. Beazely 1, Jamie K. Alan 1, Val J. Watts 1*

1 Purdue University

* Address correspondence to: E-mail: wattsv{at}pharmacy.purdue.edu

Abstract

Adenylyl cyclase type 6 (AC6) activity is inhibited by PKC in vitro, however in intact cells, PKC activation does not inhibit the activity of transiently expressed AC6. In order to investigate the effects of PKC activation on AC6 activity in intact cells, we constructed HEK293 cells that stably express wild-type AC6 (AC6-WT) or an AC6 mutant lacking a PKC and PKA phosphorylation site, Ser674 (AC6-S674A). In contrast to in vitro observations, we observed a PKC-mediated enhancement of forskolin- and isoproterenol-stimulated cyclic AMP accumulation in HEK-AC6 cells. PMA also potentiated cyclic AMP accumulation in cells expressing endogenous AC6 including CHO cells and differentiated CAD cells. In HEK-AC6-S674A cells, the potentiation of AC6 stimulation was significantly greater than in cells expressing AC6-WT. The positive effect of PKC activation on AC6 activity appeared to involve Raf1 kinase because the Raf1 inhibitor, GW5074, inhibited the PKC potentiation of AC6 activity. Further, the forskolin-stimulated activity of a recombinant AC6 in which the putative Raf1 regulatory sites have been eliminated was not potentiated by activation of PKC. The ability of Raf1 to regulate AC6 may involve a direct interaction because AC6 and a constitutively active Raf1 construct were co-immunoprecipitated. In addition, we report that EGF receptor activation also enhances AC6 signaling in a Raf1-dependent manner. These data suggest that Raf1 potentiates drug-stimulated cyclic AMP accumulation in cells expressing AC6 after activation of multiple signaling pathways.


Key words: NGF/EGF, Gs family, Adenylyl cyclases, Protein Kinase C, Raf family, Drug tolerance/dependence


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
D. Willoughby and D. M. F. Cooper
Organization and Ca2+ Regulation of Adenylyl Cyclases in cAMP Microdomains
Physiol Rev, July 1, 2007; 87(3): 965 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. Osawa, P. D. Yim, D. Xu, R. A. Panettieri, and C. W. Emala
Raf-1 kinase mediates adenylyl cyclase sensitization by TNF-{alpha} in human airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1414 - L1421.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Cai, J. C. He, L. Zhu, C. Lu, and H. Vlassara
Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor
PNAS, September 12, 2006; 103(37): 13801 - 13806.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics